7 recruiting, 2 active not recruiting, 2 completed, 2 not yet recruiting. 7 Phase 3, 5 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Recruiting 3, Not yet recruiting 2, Active not recruiting 1, Completed 1 |
| Phase 2 | 5 | Recruiting 4, Active not recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow Zasocitinib: new trials by email Literature Review of Zasocitinib trials Research Report on Zasocitinib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Zasocitinib in Adults With Psoriatic Arthritis (LATITUDE PsA NeXt) Placebo, Zasocitinib - Psoriatic Arthritis | Phase 3 | Not yet recruiting | Takeda | 644 | 2027-01-11 | 2026-10-27 |
| A Study of Zasocitinib in Adults With Non-pustular Palmoplantar Psoriasis Zasocitinib - Palmoplantar Psoriasis | Phase 3 | Not yet recruiting | Takeda | 40 | 2026-11-01 | 2026-10-20 |
| A Study of Zasocitinib (TAK-279) in Adults With Active Crohn's Disease Zasocitinib - Crohn's Disease | Phase 2 | Recruiting | Takeda | 20 | 2026-08-13 | 2026-08-24 |
| Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis Zasocitinib - Psoriatic Arthritis | Phase 3 | Recruiting | Takeda | 1182 | 2026-03-11 | 2026-09-09 |
| A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis Zasocitinib, Placebo - Plaque Psoriasis | Phase 3 | Recruiting | Takeda | 110 | 2025-12-04 | 2026-09-09 |
| A Study of Zasocitinib in Adults With Nonsegmental Vitiligo Zasocitinib, Placebo - Nonsegmental Vitiligo | Phase 2 | Recruiting | Takeda | 200 | 2025-11-03 | 2026-09-30 |
| A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis Zasocitinib, Deucravacitinib, Placebo to match zasocitinib - Plaque Psoriasis | Phase 3 | Completed | Takeda | 606 | 2025-07-09 | 2026-05-01 |
| A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD) Zasocitinib - Crohn's Disease, Ulcerative Colitis | Phase 2 | Recruiting | Takeda | 192 | 2025-05-28 | 2026-05-22 |
| A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines Zasocitinib, Placebo - Psoriatic Arthritis | Phase 3 | Active not recruiting | Takeda | 601 | 2025-03-10 | 2026-10-14 |
| A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines Zasocitinib, Active Comparator, Placebo - Psoriatic Arthritis | Phase 3 | Recruiting | Takeda | 1088 | 2025-03-03 | 2026-10-14 |
| A Study of Interaction of Zasocitinib (TAK-279) With Other Medicines in Healthy Adults Zasocitinib, COC, Metformin - Healthy Volunteers | Phase 1 | Completed | Takeda | 78 | 2025-01-23 | 2025-04-04 |
| A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis TAK-279, Placebo - Ulcerative Colitis | Phase 2 | Active not recruiting | Takeda | 213 | 2024-03-29 | 2026-08-17 |
| A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease TAK-279, Placebo - Crohn's Disease | Phase 2 | Recruiting | Takeda | 268 | 2024-03-05 | 2026-09-25 |
Arthritis, Psoriatic (4) · Crohn Disease (3) · Colitis, Ulcerative (2) · Psoriasis (1)
Takeda (13)
United States (10) · Poland (9) · China (7) · Japan (7) · Czechia (6) · Germany (6) · Canada (5) · France (5) · Hungary (5) · Italy (5) · Spain (5) · Australia (4) · Bulgaria (4) · Israel (4) · South Korea (4)
2025 (3), 2023 (2)